Nurix Therapeutics NRIX - Options Chain | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Nurix Therapeutics Inc (NRIX)
Nurix Therapeutics Inc (NRIX) Options

Nurix Therapeutics Inc (NRIX)

13.105

-0.765

( -5.52% )

Updated: 03:40:17

Delayed by 15 minutes

NRIX Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	9.90	11.70	0.00	10.80	0.00	0.00 %	0	0	-
5.00	7.30	9.10	0.00	8.20	0.00	0.00 %	0	0	-
7.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
10.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
12.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
15.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
17.50	0.70	0.15	0.70	0.425	0.00	0.00 %	0	46	-
20.00	0.00	1.00	0.00	0.00	0.00	0.00 %	0	0	-
22.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
25.00	0.75	4.40	0.75	2.575	0.00	0.00 %	0	10	-
30.00	0.00	4.40	0.00	0.00	0.00	0.00 %	0	0	-

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
5.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
7.50	0.00	4.40	0.00	0.00	0.00	0.00 %	0	0	-
10.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
12.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
15.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
17.50	3.70	5.10	1.25	4.40	0.00	0.00 %	0	1	-
20.00	6.20	7.80	0.00	7.00	0.00	0.00 %	0	0	-
22.50	8.70	10.90	0.00	9.80	0.00	0.00 %	0	0	-
25.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
30.00	16.10	17.90	0.00	17.00	0.00	0.00 %	0	0	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
RNAZTransCode Therapeutics Inc	US$ 1.35 (75.32%)	184.19M
XHLDTEN Holdings Inc	US$ 1.478 (48.19%)	52.71M
GLTOGalecto Inc	US$ 5.808 (40.29%)	8.57M
ARECAmerican Resources Corporation	US$ 0.6123 (38.53%)	3.52M
VVPRVivoPower International PLC	US$ 1.16 (36.81%)	54.64M
KZIAKazia Therapeutics Ltd	US$ 0.965 (-80.24%)	40.19k
YHCLQR House Inc	US$ 0.66 (-70.93%)	9.13M
DMNDamon Inc	US$ 0.0384 (-69.13%)	233.94M
TCBPTC BioPharm Holdings PLC	US$ 0.61 (-60.39%)	1.23M
RCTRedCloud Holdings PLC	4.065 (-44.01%)	814.11k
DMNDamon Inc	US$ 0.0384 (-69.13%)	236.14M
RNAZTransCode Therapeutics Inc	US$ 1.35 (75.32%)	185.11M
NVDANVIDIA Corporation	US$ 117.79 (-0.62%)	125.56M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 8.83 (8.21%)	117.04M
LITMSnow Lake Resources Ltd	US$ 0.6763 (12.57%)	100.79M

Monksdream

Monksdream 5 months ago

NRIX 10Q due Oct 17

Monksdream

Monksdream 5 months ago

NRIX 10 Q due 10 October

Monksdream

Monksdream 6 months ago

NRIX creeping higher

Monksdream

Monksdream 8 months ago

NRIX 10 Q expected JULY11

Monksdream

Monksdream 9 months ago

NRIX new 52 week high

Monksdream

Monksdream 10 months ago

NRIX more new highs up ahead

Monksdream

Monksdream 11 months ago

Monksdream

Monksdream 11 months ago

Monksdream

Monksdream 1 year ago

NRIX new 52 week high

TheFinalCD

TheFinalCD 3 years ago

https://ih.advfn.com/stock-market/NASDAQ/nurix-therapeutics-NRIX/stock-news/88898489/cathie-wood-doubles-down-on-these-2-strong-buy

infamous

infamous 4 years ago

what the F is wrong with this fkn stock? does it ever go up???

Phosphene

Phosphene 4 years ago

CEO: Dr. Arthur T. Sands

https://www.nurixtx.com/arthur-t-sands-m-d-ph-d/

Phosphene

Phosphene 4 years ago

Strategic partnerships with Sanofi and Gilead Sciences Inc.

https://www.nurixtx.com/research-development/strategic-partnerships/

Wellington and Baker Brothers are among Institutional Ownership and Shareholders:

https://fintel.io/so/us/nrix?__cf_chl_jschl_tk__=c9a7439112376e9f70de91c1316dfcc7e26d3519-1607403189-0-AT-0XpHMlNGWmcEzimwDKelDxLnOK6gsd8IihalGD8DcDe76KQlrWnh2Q1G3OLjfsidXSQyjVOkcCg3lXIXgKu6RIlw8DMusjRJpgnTzQP2qkahd1WSCP-5At2BI9Udfzc2vqpmlZOV3prAMIdFIh1_urJuBNq7hGlM4oSEJKFEFs8WDerUagukeDe9yBmvVg0Ne17vR8ByRaN-BlyHHxPWeTerJ_ZHoD1jnsxFYInhjhkK-XNkhe3BJ0Wzq3782kDVndNMNsb1glMkmm_NlSnc8Xbwve1nF3nGShcpgUxA-nefEgd9L74SzGXF1WftTIX4HYgwtb1BRzq82RClNfm9dr9Xb-hKp3xKKiYL4k9KfqV9OAePxDJoYgKqLUziXoA

Phosphene

Phosphene 4 years ago

Data support a planned clinical trial of NX-2127 in B-cell malignancies

http://www.globenewswire.com/news-release/2020/12/07/2140737/0/en/Nurix-Therapeutics-Presents-Preclinical-Data-at-62nd-American-Society-of-Hematology-ASH-Annual-Meeting-and-Exposition.html

Nurix Therapeutics

FTSE Italia All Share Te...

Avantis All Internationa...

Avantis US Small Cap Val...

Schwab US Large Cap Value

Direxion Daily S&P Oil&G...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions